ROBIN HOGAN: Open Payments
NPI 1427702307 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,945 in 77 payments from 14 companies in 2025. Trend: 2023 $289 · 2024 $1,190 · 2025 $1,945
Food & beverage: $1,945
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 18 | $460 |
| AstraZeneca Pharmaceuticals LP | 12 | $449 |
| ARS Pharmaceuticals Operations, Inc. | 9 | $165 |
| Novartis Pharmaceuticals Corporation | 8 | $161 |
| GlaxoSmithKline, LLC. | 7 | $137 |
| Ionis Pharmaceuticals, Inc. | 4 | $91 |
| BioCryst US Sales Co., LLC | 3 | $90 |
| CSL Behring | 3 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $82 |
| Regeneron Healthcare Solutions, Inc. | 2 | $65 |
Products named: DUPIXENT, TEZSPIRE, NEFFY, DAWNZERA, ORLADEYO, CUVITRU, NUCALA, Rhapsido.
Industry payments across GA — which companies pay providers there.
